All In Biotech

Free tool

FAERS Monitor: Vyloy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761365 or its brand name (Vyloy, Zolbetuximab-Clzb). Reports on generic versions are filed under their own applications.

Reports

1,525

Serious

1,304

86% of reports

Hospitalization

515

Death reported

178

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea558
  • vomiting271
  • decreased appetite201
  • ascites138
  • hypoalbuminaemia129
  • malignant neoplasm progression117
  • blood albumin decreased100
  • diarrhoea82
  • oedema peripheral67
  • myelosuppression66
  • neutrophil count decreased63
  • malaise62
  • oedema53
  • abdominal pain51
  • dehydration49

Reports by year received

View as table
YearReports
20197
20206
202122
20225
20236
2024100
2025772
2026607

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,634 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypoalbuminaemiaSignal129232.8197.129,066
blood albumin decreasedSignal100176.1145.517,022
ascitesSignal13865.055.58,610
myelosuppressionSignal6625.320.01,517
neutrophil count decreasedSignal6321.416.81,202
malignant neoplasm progressionSignal11715.813.31,610
oedemaSignal5313.510.4601
decreased appetiteSignal20111.910.52,025
nauseaSignal5589.79.14,529
vomitingSignal2718.07.11,677
oedema peripheralSignal677.66.0378
dehydrationSignal495.13.8157
abdominal painSignal513.02.368
malaise621.91.528
diarrhoea821.81.427

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.